Amphastar Pharmaceuticals Inc (AMPH)
50.60
-0.13
(-0.26%)
USD |
NASDAQ |
Nov 04, 16:00
50.60
0.00 (0.00%)
After-Hours: 20:00
Amphastar Pharmaceuticals Enterprise Value: 2.853B for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 2.853B |
| October 31, 2024 | 2.843B |
| October 30, 2024 | 2.856B |
| October 29, 2024 | 2.874B |
| October 28, 2024 | 2.886B |
| October 25, 2024 | 2.832B |
| October 24, 2024 | 2.799B |
| October 23, 2024 | 2.809B |
| October 22, 2024 | 2.836B |
| October 21, 2024 | 2.858B |
| October 18, 2024 | 2.859B |
| October 17, 2024 | 2.803B |
| October 16, 2024 | 2.858B |
| October 15, 2024 | 2.784B |
| October 14, 2024 | 2.783B |
| October 11, 2024 | 2.698B |
| October 10, 2024 | 2.636B |
| October 09, 2024 | 2.637B |
| October 08, 2024 | 2.635B |
| October 07, 2024 | 2.662B |
| October 04, 2024 | 2.657B |
| October 03, 2024 | 2.637B |
| October 02, 2024 | 2.646B |
| October 01, 2024 | 2.737B |
| September 30, 2024 | 2.745B |
| Date | Value |
|---|---|
| September 27, 2024 | 2.721B |
| September 26, 2024 | 2.714B |
| September 25, 2024 | 2.657B |
| September 24, 2024 | 2.690B |
| September 23, 2024 | 2.749B |
| September 20, 2024 | 2.777B |
| September 19, 2024 | 2.822B |
| September 18, 2024 | 2.807B |
| September 17, 2024 | 2.751B |
| September 16, 2024 | 2.738B |
| September 13, 2024 | 2.724B |
| September 12, 2024 | 2.647B |
| September 11, 2024 | 2.576B |
| September 10, 2024 | 2.541B |
| September 09, 2024 | 2.550B |
| September 06, 2024 | 2.591B |
| September 05, 2024 | 2.593B |
| September 04, 2024 | 2.666B |
| September 03, 2024 | 2.670B |
| August 30, 2024 | 2.756B |
| August 29, 2024 | 2.762B |
| August 28, 2024 | 2.747B |
| August 27, 2024 | 2.743B |
| August 26, 2024 | 2.727B |
| August 23, 2024 | 2.717B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
593.31M
Minimum
Mar 20 2020
3.514B
Maximum
Aug 08 2023
1.576B
Average
1.283B
Median
Nov 22 2022
Enterprise Value Benchmarks
| Omeros Corp | 268.91M |
| Harrow Inc | 1.733B |
| PetIQ Inc | -- |
| Alector Inc | -14.78M |
| Outset Medical Inc | 33.92M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 37.95M |
| Revenue (Quarterly) | 182.39M |
| Total Expenses (Quarterly) | 127.18M |
| EPS Diluted (Quarterly) | 0.73 |
| Gross Profit Margin (Quarterly) | 52.18% |
| Profit Margin (Quarterly) | 20.81% |
| Earnings Yield | 6.19% |
| Operating Earnings Yield | 8.57% |
| Normalized Earnings Yield | 6.186 |